AI-generated analysis. Always verify with the original filing.
Ascentage Pharma Group International announced that a Board meeting will be held on March 25, 2026, to consider and approve the Group's annual results for the year ended December 31, 2025, and to consider declaring a final dividend, if any. This provides investors with the anticipated timing for full-year financial results disclosure.